The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Drugs for preventing malaria in pregnant women
Abstract
BACKGROUND: Malaria contributes to maternal illness and anaemia in pregnancy, especially in first-time mothers, and can harm the mother and the baby. Drugs given routinely to prevent or mitigate the effects of malaria during pregnancy are often recommended. OBJECTIVES: To assess drugs given to prevent malaria infection and its consequences in pregnant women living in malarial areas. This includes prophylaxis and intermittent preventive treatment (IPT). SEARCH STRATEGY: We searched the Cochrane Infectious Diseases Group Specialized Register (March 2006), CENTRAL (The Cochrane Library 2006, Issue 1), MEDLINE (1966 to March 2006), EMBASE (1974 to March 2006), LILACS (1982 to March 2006), and reference lists. We also contacted researchers working in the field. SELECTION CRITERIA: Randomized and quasi-randomized controlled trials comparing antimalarial drugs given regularly with no antimalarial drugs for preventing malaria in pregnant women living in malaria-endemic areas. DATA COLLECTION AND ANALYSIS: Both authors extracted data and assessed methodological quality. Dichotomous variables were combined using relative risks (RR) and weighted mean differences (WMD) for mean values, both with 95% confidence intervals (CI). MAIN RESULTS: Sixteen trials (12,638 participants) met the inclusion criteria; two used adequate methods to conceal allocation. Antimalarials reduced antenatal parasitaemia when given to all pregnant women (RR 0.53, 95% CI 0.33 to 0.86; 328 participants, 2 trials), placental malaria (RR 0.34, 95% CI 0.26 to 0.45; 1236 participants, 3 trials), but no effect was detected with perinatal deaths (2890 participants, 4 trials). In women in their first or second pregnancy, antimalarial drugs reduced severe antenatal anaemia (RR 0.62, 95% CI 0.50 to 0.78; 2809 participants, 1 prophylaxis and 2 IPT trials), antenatal parasitaemia (RR 0.27, 95% CI 0.17 to 0.44, random-effects model; 2906 participants, 6 trials), and perinatal deaths (RR 0.73, 95% CI 0.53 to 0.99; 1986 participants, 2 prophylaxis and 1 IPT trial; mean birthweight was higher (WMD 126.70 g, 95% CI 88.64 to 164.75 g; 2648 participants, 8 trials), and low birthweight less frequent (RR 0.57, 95% CI 0.46 to 0.72; 2350 participants, 6 trials). Proguanil performed better than chloroquine in one trial of women of all parities in relation to maternal fever episodes. Sulfadoxine-pyrimethamine performed better than chloroquine in two trials of low-parity women. AUTHORS' CONCLUSIONS: Chemoprophylaxis or IPT reduces antenatal parasite prevalence and placental malaria when given to women in all parity groups. They also have positive effects on birthweight and possibly on perinatal death in low-parity women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kayentao, K., Kodio, M., Newman, R. D., Maiga, H., Doumtabe, D., Ongoiba, A., Coulibaly, D., Keita, A. S., Maiga, B., Mungai, M., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/426400 · Cited by 162
Challis, K., Osman, N. B., Cotiro, M., Nordahl, G., Dgedge, M., & Bergström, S. (2004) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2004.01307.x · Cited by 58
Cited by
Bhutta, Z. A., Das, J. K., Rizvi, A., Gaffey, M. F., Walker, N., Horton, S., Webb, P., Lartey, A., & Black, R. E. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60996-4 · Cited by 3,093
Renfrew, M. J., McFadden, A., Bastos, M. H., Campbell, J., Channon, A. A., Cheung, N. F., Silva, D. R. A. D., Downe, S., Kennedy, H. P., Malata, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60789-3 · Cited by 1,297
Hookworm-Related Anaemia among Pregnant Women: A Systematic Review
Brooker, S., Hotez, P. J., & Bundy, D. A. P. (2008) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000291 · Cited by 422
Risk factors for small for gestational age infants
McCowan, L., & Horgan, R. P. (2009) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2009.06.003 · Cited by 346
Simmons, L. E., Rubens, C. E., Darmstadt, G. L., & Gravett, M. G. (2010) · Seminars in Perinatology · doi:10.1053/j.semperi.2010.09.005 · Cited by 312
Stillbirths: what difference can we make and at what cost?
Bhutta, Z. A., Yakoob, M. Y., Lawn, J. E., Rizvi, A., Friberg, I. K., Weissman, E., Buchmann, E., & Goldenberg, R. L. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62269-6 · Cited by 306
Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions
the GAPPS Review Group, Barros, F. C., Bhutta, Z. A., Batra, M., Hansen, T. N., Victora, C. G., & Rubens, C. E. (2010) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-10-s1-s3 · Cited by 300
Malaria and pregnancy: a global health perspective.
(2009) · PubMed Central · Cited by 278
Eisele, T. P., Larsen, D. A., Anglewicz, P. A., Keating, J., Yukich, J., Bennett, A., Hutchinson, P., & Steketee, R. W. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70222-0 · Cited by 253
Safety of dermatologic medications in pregnancy and lactation
Murase, J. E., Heller, M. M., & Butler, D. C. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.09.010 · Cited by 220
Malaria in pregnancy: small babies, big problem
Umbers, A. J., Aitken, E. H., & Rogerson, S. J. (2011) · Trends in Parasitology · doi:10.1016/j.pt.2011.01.007 · Cited by 200
Fried, M., & Duffy, P. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025551 · Cited by 202
Non-placental causes of intrauterine growth restriction
Hendrix, N., & Berghella, V. (2008) · Seminars in Perinatology · doi:10.1053/j.semperi.2008.02.004 · Cited by 188
Malaria Prevention with IPTp during Pregnancy Reduces Neonatal Mortality
Menéndez, C., Bardají, A., Sigauque, B., Sanz, S., Aponte, J. J., Mabunda, S., & Alonso, P. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009438 · Cited by 135
Iron, anemia and hepcidin in malaria
Spottiswoode, N., Duffy, P. E., & Drakesmith, H. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00125 · Cited by 127
Comparison of real-time PCR and microscopy for malaria parasite detection in Malawian pregnant women
Rantala, A.-M., Taylor, S. M., Trottman, P. A., Luntamo, M., Mbewe, B., Maleta, K., Kulmala, T., Ashorn, P., & Meshnick, S. R. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-269 · Cited by 110
McClure, E. M., Goldenberg, R. L., Dent, A. E., & Meshnick, S. R. (2013) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2012.12.014 · Cited by 78
Mutabingwa, T. K., Muze, K., Ord, R., Briceño, M., Greenwood, B. M., Drakeley, C., & Whitty, C. J. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005138 · Cited by 53
“This is especially important in the case of IPTp, for which drugs must have a proven safety record as they will frequently be given to women who are not parasitaemic [39,40].”
Newman, P. M., Wanzira, H., Tumwine, G., Arinaitwe, E., Waldman, S., Achan, J., Havlir, D., Rosenthal, P. J., Dorsey, G., Clark, T. D., et al. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-254 · Cited by 42
Ndyomugyenyi, R., Clarke, S. E., Hutchison, C. L., Hansen, K. S., & Magnussen, P. (2011) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2011.07.012 · Cited by 42
Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy
Chico, R. M., & Chandramohan, D. (2011) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2011.02765.x · Cited by 38
Ameyaw, E. K. (2022) · Malaria Journal · doi:10.1186/s12936-022-04299-z · Cited by 21
Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women
Mathanga, D. P., Uthman, O. A., & Chinkhumba, J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006689.pub2 · Cited by 19
Metadata
- Authors
- Garner, P., & Gülmezoglu, A. M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2006-10-18
- Issue
- 4
- Pages
- CD000169-CD000169
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W1829969880
- Cited by
- 183
- References
- 2
- Type
- reference entry
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.